recombinant SSDF program (Stainwei Biotech)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namerecombinant SSDF program (Stainwei Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGrowth factor receptors modulators
TargetsGrowth factor receptors
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSuzhou Stainwei Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Stainwei Biotech Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A